Trial Profile
A parallel-group, pharmacokinetic study to evaluate the efficacy of nevirapine and lopinavir/ritonavir in HIV-infected patients with drug-resistant tuberculosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Mar 2016
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Nevirapine (Primary) ; Antiretrovirals
- Indications HIV infections; Tuberculosis
- Focus Pharmacokinetics
- 18 Mar 2016 New trial record